… and Northern Ireland

BMJ

Volumn 313, Issue 7060, 1996, Pages 820-

  Goldsmith, C E ^a   Moore, J E ^a   Murphy, P G ^a  

^a BELFAST CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

DRUG EFFECT; HUMAN; NOTE; PENICILLIN RESISTANCE; PREVALENCE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; UNITED KINGDOM;

ANTI-BACTERIAL AGENTS; HUMANS; NORTHERN IRELAND; PENICILLIN RESISTANCE; PNEUMOCOCCAL INFECTIONS; PREVALENCE; STREPTOCOCCUS PNEUMONIAE;

EID: 85007772282     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.313.7060.820a     Document Type: Letter

References (5)

1. Johnson AP, Speller DCE, George RC, Warner M, Domingue G, Efstratiou A. Prevalence of antibiotic resistance and serotypes in pneumococci in England and Wales: results of observational surveys in 1990 and 1995. BMJ 1996; 312: 1454–6. (8 June.)
2. Lafong AC, Crothers E, Bamford KB, Rooney PJ. Distribution of serotypes and antibiotic resistance among pneumococci in N Ireland. J Infect 1988; 16: 235–242.
3. Johnson AP, Speller DCE, Patel BC. Sensitivity to cefotaxime of pneumococci isolated in the UK. J Antimicrob Chemother 1995; 35: 443–444.
4. Soares S, Kristinsson KG, Musser JM, Tomasz A. Evidence of the introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the last 1890s. J Infect Dis 1993; 168: 156–163.
5. Centers for Disease Control and Prevention. Defining the public health impact of drug resistant Streptococcus pneumoniae: report of a working group. MMWR 1996; 45: No RR-1.